Frauke Pedersen

Key mechanisms governing resolution of lung inflammation

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice

Reading the glyco-code: New approaches to studying protein–carbohydrate interactions

Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease

Anemia and Cardiovascular Disease, Hospitalization, End Stage Renal Disease, and Death in Older Patients with Chronic Kidney Disease

Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life, and Cardiovascular Risk

Macrophages in immunoregulation and therapeutics

EBPG Guideline on Nutrition

NETosis: Molecular Mechanisms, Role in Physiology and Pathology

Chronic kidney disease

Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism

Inflammation and tumor progression: signaling pathways and targeted intervention

Tuberculosis and lung damage: from epidemiology to pathophysiology

Multiple Roles for Chemokines in Neutrophil Biology

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

Uraemic sarcopenia: aetiology and implications

Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?

Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

In vivo evidence for extracellular DNA trap formation

Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19

Neutrophils and NETs in modulating acute and chronic inflammation

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy

Inflammatory responses and inflammation-associated diseases in organs

Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation

Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial

Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients

NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma

Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial

Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial

Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD

Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.

[Quality of life of hemodialysis patients before and after erythropoietin therapy. A double-blind, randomized, placebo controlled study].